

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.35498851 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.68421563 |
| 3 | angiotensin maturation (GO:0002003) | 7.11004514 |
| 4 | intestinal cholesterol absorption (GO:0030299) | 6.92989817 |
| 5 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 6.33880718 |
| 6 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.99867866 |
| 7 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.86652269 |
| 8 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.86652269 |
| 9 | endocrine process (GO:0050886) | 5.86652269 |
| 10 | hormone catabolic process (GO:0042447) | 5.86303166 |
| 11 | actin filament depolymerization (GO:0030042) | 5.75741802 |
| 12 | drug catabolic process (GO:0042737) | 5.61734707 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 5.58616113 |
| 14 | drug transmembrane transport (GO:0006855) | 5.54537156 |
| 15 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.50862439 |
| 16 | drug transport (GO:0015893) | 5.45886623 |
| 17 | intestinal epithelial cell development (GO:0060576) | 5.38942939 |
| 18 | regulation of cellular extravasation (GO:0002691) | 5.24714142 |
| 19 | regulation of systemic arterial blood pressure (GO:0003073) | 5.24650045 |
| 20 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.15888841 |
| 21 | flavonoid metabolic process (GO:0009812) | 5.07644028 |
| 22 | vitamin A metabolic process (GO:0006776) | 5.02316463 |
| 23 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.81184297 |
| 24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.79553936 |
| 25 | digestive system process (GO:0022600) | 4.77418966 |
| 26 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.70390399 |
| 27 | cellular glucuronidation (GO:0052695) | 4.67608216 |
| 28 | regulation of cGMP biosynthetic process (GO:0030826) | 4.65480492 |
| 29 | glucuronate metabolic process (GO:0019585) | 4.54384991 |
| 30 | uronic acid metabolic process (GO:0006063) | 4.54384991 |
| 31 | urea cycle (GO:0000050) | 4.49720511 |
| 32 | O-glycan processing (GO:0016266) | 4.48713770 |
| 33 | regulation of bile acid biosynthetic process (GO:0070857) | 4.39327532 |
| 34 | modified amino acid transport (GO:0072337) | 4.38849880 |
| 35 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.29848979 |
| 36 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.29848979 |
| 37 | urate metabolic process (GO:0046415) | 4.28556864 |
| 38 | renal absorption (GO:0070293) | 4.25459454 |
| 39 | peptide hormone processing (GO:0016486) | 4.24675166 |
| 40 | urea metabolic process (GO:0019627) | 4.22768635 |
| 41 | sulfate transmembrane transport (GO:1902358) | 4.16682162 |
| 42 | epithelial structure maintenance (GO:0010669) | 4.12827397 |
| 43 | regulation of vitamin metabolic process (GO:0030656) | 4.05759268 |
| 44 | positive regulation of respiratory burst (GO:0060267) | 4.05301051 |
| 45 | sulfur compound transport (GO:0072348) | 4.04109645 |
| 46 | renal system process involved in regulation of blood volume (GO:0001977) | 4.01895753 |
| 47 | bicarbonate transport (GO:0015701) | 4.01177321 |
| 48 | peptide catabolic process (GO:0043171) | 3.98898144 |
| 49 | positive regulation of pseudopodium assembly (GO:0031274) | 3.91244901 |
| 50 | glucose 6-phosphate metabolic process (GO:0051156) | 3.89656426 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 3.89175448 |
| 52 | lysine metabolic process (GO:0006553) | 3.87479273 |
| 53 | lysine catabolic process (GO:0006554) | 3.87479273 |
| 54 | regulation of cGMP metabolic process (GO:0030823) | 3.85949031 |
| 55 | excretion (GO:0007588) | 3.84126044 |
| 56 | arginine metabolic process (GO:0006525) | 3.83911772 |
| 57 | transepithelial transport (GO:0070633) | 3.83834513 |
| 58 | adhesion of symbiont to host cell (GO:0044650) | 3.80701728 |
| 59 | virion attachment to host cell (GO:0019062) | 3.80701728 |
| 60 | regulation of cholesterol homeostasis (GO:2000188) | 3.79030785 |
| 61 | regulation of pseudopodium assembly (GO:0031272) | 3.78825376 |
| 62 | exogenous drug catabolic process (GO:0042738) | 3.78013747 |
| 63 | toxin transport (GO:1901998) | 3.76952378 |
| 64 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68827566 |
| 65 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.64888347 |
| 66 | fructose metabolic process (GO:0006000) | 3.64796862 |
| 67 | antimicrobial humoral response (GO:0019730) | 3.62300577 |
| 68 | homocysteine metabolic process (GO:0050667) | 3.60122487 |
| 69 | glycolipid catabolic process (GO:0019377) | 3.60088321 |
| 70 | digestion (GO:0007586) | 3.58190906 |
| 71 | thyroid hormone metabolic process (GO:0042403) | 3.56016245 |
| 72 | NADH metabolic process (GO:0006734) | 3.55984092 |
| 73 | glycosphingolipid catabolic process (GO:0046479) | 3.55457942 |
| 74 | antibacterial humoral response (GO:0019731) | 3.55219291 |
| 75 | polyol transport (GO:0015791) | 3.53400045 |
| 76 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.51016488 |
| 77 | glomerular filtration (GO:0003094) | 3.46360711 |
| 78 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.46175426 |
| 79 | purine nucleotide salvage (GO:0032261) | 3.45667512 |
| 80 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.45645395 |
| 81 | bile acid and bile salt transport (GO:0015721) | 3.43003163 |
| 82 | midgut development (GO:0007494) | 3.41460837 |
| 83 | organic cation transport (GO:0015695) | 3.38427427 |
| 84 | hemidesmosome assembly (GO:0031581) | 3.37404659 |
| 85 | sulfate transport (GO:0008272) | 3.34850705 |
| 86 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.30428714 |
| 87 | response to hepatocyte growth factor (GO:0035728) | 3.30428714 |
| 88 | transcytosis (GO:0045056) | 3.30298982 |
| 89 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.27519343 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 3.25261020 |
| 91 | negative regulation of sterol transport (GO:0032372) | 3.25261020 |
| 92 | positive regulation of digestive system process (GO:0060456) | 3.25100967 |
| 93 | drinking behavior (GO:0042756) | 3.24789949 |
| 94 | sulfation (GO:0051923) | 3.24650912 |
| 95 | phosphate ion transport (GO:0006817) | 3.24032836 |
| 96 | cGMP biosynthetic process (GO:0006182) | 3.23608757 |
| 97 | oligosaccharide catabolic process (GO:0009313) | 3.22752583 |
| 98 | lipoprotein metabolic process (GO:0042157) | 3.22643448 |
| 99 | hydrogen peroxide catabolic process (GO:0042744) | 3.22585363 |
| 100 | membrane repolarization during action potential (GO:0086011) | 3.22471615 |
| 101 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.17340796 |
| 102 | ceramide catabolic process (GO:0046514) | 3.16477985 |
| 103 | renal filtration (GO:0097205) | 3.15771255 |
| 104 | mRNA modification (GO:0016556) | 3.14046564 |
| 105 | sperm capacitation (GO:0048240) | 3.12016877 |
| 106 | auditory receptor cell differentiation (GO:0042491) | 3.11243866 |
| 107 | alkaloid metabolic process (GO:0009820) | 3.11180876 |
| 108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10557674 |
| 109 | vitamin transmembrane transport (GO:0035461) | 3.09969308 |
| 110 | hepatocyte apoptotic process (GO:0097284) | 3.08467766 |
| 111 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.08131392 |
| 112 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.07784645 |
| 113 | glutathione derivative biosynthetic process (GO:1901687) | 3.06694859 |
| 114 | glutathione derivative metabolic process (GO:1901685) | 3.06694859 |
| 115 | phosphate ion transmembrane transport (GO:0035435) | 3.06578394 |
| 116 | glycerol metabolic process (GO:0006071) | 3.06304441 |
| 117 | plasma lipoprotein particle assembly (GO:0034377) | 3.05810652 |
| 118 | glomerulus development (GO:0032835) | 3.04951165 |
| 119 | cellular response to nitric oxide (GO:0071732) | 3.04536949 |
| 120 | cysteine metabolic process (GO:0006534) | 3.04047169 |
| 121 | regulation of triglyceride catabolic process (GO:0010896) | 3.03860853 |
| 122 | bile acid metabolic process (GO:0008206) | 3.02888884 |
| 123 | quaternary ammonium group transport (GO:0015697) | 3.02882306 |
| 124 | glutathione biosynthetic process (GO:0006750) | 3.02472234 |
| 125 | oligosaccharide biosynthetic process (GO:0009312) | 3.02388705 |
| 126 | positive regulation of cGMP metabolic process (GO:0030825) | 3.01336805 |
| 127 | phospholipid scrambling (GO:0017121) | 2.99995259 |
| 128 | cellular carbohydrate catabolic process (GO:0044275) | 2.99698488 |
| 129 | fucose catabolic process (GO:0019317) | 2.98852575 |
| 130 | L-fucose metabolic process (GO:0042354) | 2.98852575 |
| 131 | L-fucose catabolic process (GO:0042355) | 2.98852575 |
| 132 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.98326355 |
| 133 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.97546668 |
| 134 | lipoprotein transport (GO:0042953) | 2.96885318 |
| 135 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.96608827 |
| 136 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.96318787 |
| 137 | regulation of digestive system process (GO:0044058) | 2.96224761 |
| 138 | sterol homeostasis (GO:0055092) | 2.96104830 |
| 139 | citrulline biosynthetic process (GO:0019240) | 2.95882713 |
| 140 | fat-soluble vitamin metabolic process (GO:0006775) | 2.95702215 |
| 141 | response to phenylpropanoid (GO:0080184) | 2.95332312 |
| 142 | cGMP-mediated signaling (GO:0019934) | 2.94512389 |
| 143 | adhesion of symbiont to host (GO:0044406) | 2.93382772 |
| 144 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.93194073 |
| 145 | protein-lipid complex assembly (GO:0065005) | 2.92782333 |
| 146 | drug metabolic process (GO:0017144) | 2.92296885 |
| 147 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91743226 |
| 148 | cholesterol homeostasis (GO:0042632) | 2.89292150 |
| 149 | diacylglycerol metabolic process (GO:0046339) | 2.88200528 |
| 150 | protein O-linked glycosylation (GO:0006493) | 2.88119348 |
| 151 | sphingolipid catabolic process (GO:0030149) | 2.87879588 |
| 152 | regulation of protein glycosylation (GO:0060049) | 2.86760201 |
| 153 | glycosylceramide metabolic process (GO:0006677) | 2.85716447 |
| 154 | phospholipid efflux (GO:0033700) | 2.85205032 |
| 155 | glycoside metabolic process (GO:0016137) | 2.84147648 |
| 156 | positive regulation of lipid catabolic process (GO:0050996) | 2.83667320 |
| 157 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.81492339 |
| 158 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.81492339 |
| 159 | response to nitric oxide (GO:0071731) | 2.81391796 |
| 160 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.80748588 |
| 161 | striated muscle atrophy (GO:0014891) | 2.80319049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.94956811 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.74483484 |
| 3 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.81691783 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.44282177 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.36981390 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.24580412 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.13278866 |
| 8 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.02030439 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.01610222 |
| 10 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.81156777 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.79161543 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76063388 |
| 13 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.60419966 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50573947 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46677896 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.40363168 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26912176 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.23182838 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.20505021 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.03211547 |
| 21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.02944979 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.96975637 |
| 23 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.96343427 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95714689 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.86064277 |
| 26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.83250429 |
| 27 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.83021999 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78424351 |
| 29 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77872084 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72347370 |
| 31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.70992134 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69913613 |
| 33 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64587618 |
| 34 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.61087894 |
| 35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58338310 |
| 36 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.58313898 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56850415 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56155647 |
| 39 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.51399134 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51083695 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46188188 |
| 42 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44665323 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42351255 |
| 44 | GATA2_19941826_ChIP-Seq_K562_Human | 1.41578093 |
| 45 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40629101 |
| 46 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40579902 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.39346439 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31370607 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.30477126 |
| 50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.29973346 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27566857 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26521806 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25868841 |
| 54 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.25556138 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23194912 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22214580 |
| 57 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21706881 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21698166 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19659949 |
| 60 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.15700173 |
| 61 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13594816 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10553822 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08981339 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06594874 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05772636 |
| 66 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.03289649 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02593969 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02522100 |
| 69 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01469525 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01294481 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98462878 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98414843 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98201265 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98201265 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97937123 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96701521 |
| 77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96488461 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96259554 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93345625 |
| 80 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92505897 |
| 81 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.92156371 |
| 82 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.90823668 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89065982 |
| 84 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89058259 |
| 85 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88082624 |
| 86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85895013 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85732169 |
| 88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85321536 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84937527 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84548630 |
| 91 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.84507623 |
| 92 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84232086 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84149239 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83809617 |
| 95 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83033229 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.82829944 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82400947 |
| 98 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.81962039 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81464002 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81177830 |
| 101 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.81171635 |
| 102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80862075 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.80793663 |
| 104 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80577186 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80177321 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78436316 |
| 107 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78027289 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77940076 |
| 109 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.77632229 |
| 110 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.77014454 |
| 111 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76661405 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76517543 |
| 113 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76452027 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76283059 |
| 115 | SPI1_23127762_ChIP-Seq_K562_Human | 0.75920258 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75500874 |
| 117 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75351060 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75191371 |
| 119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.74762120 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74476139 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.74215810 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74152131 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.73819307 |
| 124 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.73794511 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.73772723 |
| 126 | P68_20966046_ChIP-Seq_HELA_Human | 0.73689020 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.73363815 |
| 128 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.73151970 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72970942 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72694490 |
| 131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.72649790 |
| 132 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72608648 |
| 133 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71664536 |
| 134 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71234741 |
| 135 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70349203 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70127438 |
| 137 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.69810823 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69616057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.44838286 |
| 2 | MP0001666_abnormal_nutrient_absorption | 4.34874941 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.17249671 |
| 4 | MP0004043_abnormal_pH_regulation | 3.87715716 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.54383244 |
| 6 | MP0003866_abnormal_defecation | 3.47001282 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.32505675 |
| 8 | MP0000462_abnormal_digestive_system | 3.12457023 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.01660769 |
| 10 | MP0001873_stomach_inflammation | 2.81367282 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.57310748 |
| 12 | MP0001663_abnormal_digestive_system | 2.57144892 |
| 13 | MP0003283_abnormal_digestive_organ | 2.53209208 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.45032184 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.44703749 |
| 16 | MP0003878_abnormal_ear_physiology | 2.40512479 |
| 17 | MP0005377_hearing/vestibular/ear_phenot | 2.40512479 |
| 18 | MP0003252_abnormal_bile_duct | 2.40121356 |
| 19 | MP0005381_digestive/alimentary_phenotyp | 2.36729188 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.35993017 |
| 21 | MP0001765_abnormal_ion_homeostasis | 2.35536991 |
| 22 | MP0004270_analgesia | 2.30546879 |
| 23 | MP0009643_abnormal_urine_homeostasis | 2.27433518 |
| 24 | MP0000490_abnormal_crypts_of | 2.18383355 |
| 25 | MP0005365_abnormal_bile_salt | 2.17724551 |
| 26 | MP0005332_abnormal_amino_acid | 2.11563044 |
| 27 | MP0000538_abnormal_urinary_bladder | 2.09583552 |
| 28 | MP0001664_abnormal_digestion | 2.06834860 |
| 29 | MP0002822_catalepsy | 2.01888787 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.99687109 |
| 31 | MP0009840_abnormal_foam_cell | 1.85790222 |
| 32 | MP0005636_abnormal_mineral_homeostasis | 1.84652677 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.83907118 |
| 34 | MP0004858_abnormal_nervous_system | 1.80301776 |
| 35 | MP0004147_increased_porphyrin_level | 1.70129520 |
| 36 | MP0000477_abnormal_intestine_morphology | 1.70050805 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.57263842 |
| 38 | MP0002136_abnormal_kidney_physiology | 1.56348553 |
| 39 | MP0001756_abnormal_urination | 1.51596342 |
| 40 | MP0006054_spinal_hemorrhage | 1.50853883 |
| 41 | MP0003868_abnormal_feces_composition | 1.42102885 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.39122467 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.37719404 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.34518604 |
| 45 | MP0008004_abnormal_stomach_pH | 1.31115336 |
| 46 | MP0004885_abnormal_endolymph | 1.24824302 |
| 47 | MP0002796_impaired_skin_barrier | 1.23533035 |
| 48 | MP0001188_hyperpigmentation | 1.22036091 |
| 49 | MP0005310_abnormal_salivary_gland | 1.20201051 |
| 50 | MP0002089_abnormal_postnatal_growth/wei | 1.13098825 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.12531976 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.10904993 |
| 53 | MP0009379_abnormal_foot_pigmentation | 1.10592514 |
| 54 | MP0001849_ear_inflammation | 1.09957438 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.08250487 |
| 56 | MP0002971_abnormal_brown_adipose | 1.05342144 |
| 57 | MP0005670_abnormal_white_adipose | 1.02945978 |
| 58 | MP0003195_calcinosis | 1.02929344 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.02620122 |
| 60 | MP0010678_abnormal_skin_adnexa | 1.02042544 |
| 61 | MP0008872_abnormal_physiological_respon | 0.99943672 |
| 62 | MP0001764_abnormal_homeostasis | 0.99893751 |
| 63 | MP0001485_abnormal_pinna_reflex | 0.98092271 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 0.97929257 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 0.94312242 |
| 66 | MP0002876_abnormal_thyroid_physiology | 0.93805615 |
| 67 | MP0000609_abnormal_liver_physiology | 0.93679761 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.92687193 |
| 69 | MP0004484_altered_response_of | 0.92399084 |
| 70 | MP0005535_abnormal_body_temperature | 0.91440594 |
| 71 | MP0005166_decreased_susceptibility_to | 0.91432825 |
| 72 | MP0004947_skin_inflammation | 0.91224005 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 0.88056775 |
| 74 | MP0002896_abnormal_bone_mineralization | 0.87617836 |
| 75 | MP0000470_abnormal_stomach_morphology | 0.85833407 |
| 76 | MP0005501_abnormal_skin_physiology | 0.85405560 |
| 77 | MP0003718_maternal_effect | 0.84727735 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 0.83798612 |
| 79 | MP0002098_abnormal_vibrissa_morphology | 0.82978863 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82164830 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 0.80183674 |
| 82 | MP0000467_abnormal_esophagus_morphology | 0.78580026 |
| 83 | MP0005451_abnormal_body_composition | 0.78105157 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.74377005 |
| 85 | MP0000249_abnormal_blood_vessel | 0.73833473 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.73497478 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.71396933 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.69825175 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.69336031 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 0.69020668 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.66826820 |
| 92 | MP0009115_abnormal_fat_cell | 0.66333603 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.65966454 |
| 94 | MP0005330_cardiomyopathy | 0.64569887 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.64193122 |
| 96 | MP0005448_abnormal_energy_balance | 0.62026658 |
| 97 | MP0000749_muscle_degeneration | 0.61387092 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.61262061 |
| 99 | MP0006138_congestive_heart_failure | 0.61212196 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.61092541 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.60678032 |
| 102 | MP0009642_abnormal_blood_homeostasis | 0.58810136 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.58344919 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.55460740 |
| 105 | MP0005409_darkened_coat_color | 0.55386027 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.55010321 |
| 107 | MP0002254_reproductive_system_inflammat | 0.53917965 |
| 108 | MP0003879_abnormal_hair_cell | 0.53855421 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.53656718 |
| 110 | MP0003448_altered_tumor_morphology | 0.52822821 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.52343174 |
| 112 | MP0003953_abnormal_hormone_level | 0.50796228 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.50156578 |
| 114 | MP0008469_abnormal_protein_level | 0.50068179 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.49993191 |
| 116 | MP0000751_myopathy | 0.49713796 |
| 117 | MP0000678_abnormal_parathyroid_gland | 0.49017968 |
| 118 | MP0003646_muscle_fatigue | 0.48600797 |
| 119 | MP0005334_abnormal_fat_pad | 0.48323935 |
| 120 | MP0000604_amyloidosis | 0.48050763 |
| 121 | MP0005165_increased_susceptibility_to | 0.47827457 |
| 122 | MP0005025_abnormal_response_to | 0.47420636 |
| 123 | MP0001544_abnormal_cardiovascular_syste | 0.46989990 |
| 124 | MP0005385_cardiovascular_system_phenoty | 0.46989990 |
| 125 | MP0003329_amyloid_beta_deposits | 0.45498705 |
| 126 | MP0000613_abnormal_salivary_gland | 0.45316958 |
| 127 | MP0000427_abnormal_hair_cycle | 0.44676946 |
| 128 | MP0003724_increased_susceptibility_to | 0.44662885 |
| 129 | MP0003315_abnormal_perineum_morphology | 0.43953925 |
| 130 | MP0000377_abnormal_hair_follicle | 0.43009377 |
| 131 | MP0002006_tumorigenesis | 0.42881020 |
| 132 | MP0009764_decreased_sensitivity_to | 0.41519781 |
| 133 | MP0009785_altered_susceptibility_to | 0.41297318 |
| 134 | MP0002135_abnormal_kidney_morphology | 0.40002687 |
| 135 | MP0004742_abnormal_vestibular_system | 0.39194145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 7.62101596 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 7.02656529 |
| 3 | Abnormality of chloride homeostasis (HP:0011422) | 7.00790954 |
| 4 | Ileus (HP:0002595) | 6.84919330 |
| 5 | Hypokalemic alkalosis (HP:0001949) | 5.30163470 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.09826669 |
| 7 | Increased circulating renin level (HP:0000848) | 4.80119622 |
| 8 | Hyperaldosteronism (HP:0000859) | 4.73543205 |
| 9 | Abnormality of renin-angiotensin system (HP:0000847) | 4.33612213 |
| 10 | Alkalosis (HP:0001948) | 4.30348834 |
| 11 | Abnormal urine output (HP:0012590) | 4.28726276 |
| 12 | Malnutrition (HP:0004395) | 4.24489706 |
| 13 | Hypomagnesemia (HP:0002917) | 4.22243871 |
| 14 | Abnormality of magnesium homeostasis (HP:0004921) | 4.09711725 |
| 15 | Abnormality of renal excretion (HP:0011036) | 4.04051040 |
| 16 | Polyuria (HP:0000103) | 3.88902288 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.84464191 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.84271518 |
| 19 | Dehydration (HP:0001944) | 3.53934187 |
| 20 | Renal salt wasting (HP:0000127) | 3.52344760 |
| 21 | Hydroxyprolinuria (HP:0003080) | 3.49065020 |
| 22 | Abnormality of proline metabolism (HP:0010907) | 3.49065020 |
| 23 | Tetany (HP:0001281) | 3.28085614 |
| 24 | Gout (HP:0001997) | 3.22029747 |
| 25 | Abnormality of urine glucose concentration (HP:0011016) | 3.20664693 |
| 26 | Glycosuria (HP:0003076) | 3.20664693 |
| 27 | Proximal tubulopathy (HP:0000114) | 3.18613165 |
| 28 | Hypokalemia (HP:0002900) | 3.17206949 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.17031625 |
| 30 | Abnormality of purine metabolism (HP:0004352) | 3.16677695 |
| 31 | Nausea (HP:0002018) | 3.06038171 |
| 32 | Widely patent fontanelles and sutures (HP:0004492) | 3.01308978 |
| 33 | Hyperglycinuria (HP:0003108) | 2.99913502 |
| 34 | Abdominal distention (HP:0003270) | 2.99128590 |
| 35 | Congenital sensorineural hearing impairment (HP:0008527) | 2.94106824 |
| 36 | Chronic diarrhea (HP:0002028) | 2.90813992 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.89473007 |
| 38 | Acanthocytosis (HP:0001927) | 2.86151561 |
| 39 | Onycholysis (HP:0001806) | 2.84234157 |
| 40 | Increased purine levels (HP:0004368) | 2.83252766 |
| 41 | Hyperuricemia (HP:0002149) | 2.83252766 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.82464429 |
| 43 | Hypercalciuria (HP:0002150) | 2.78677562 |
| 44 | Xanthomatosis (HP:0000991) | 2.69206019 |
| 45 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.66228333 |
| 46 | Hyperphosphatemia (HP:0002905) | 2.66169356 |
| 47 | Hyperphosphaturia (HP:0003109) | 2.65069994 |
| 48 | Steatorrhea (HP:0002570) | 2.63861088 |
| 49 | Abnormal drinking behavior (HP:0030082) | 2.61457518 |
| 50 | Polydipsia (HP:0001959) | 2.61457518 |
| 51 | Hyponatremia (HP:0002902) | 2.59603220 |
| 52 | Flat acetabular roof (HP:0003180) | 2.59017897 |
| 53 | Hyperparathyroidism (HP:0000843) | 2.55841373 |
| 54 | Pustule (HP:0200039) | 2.53595711 |
| 55 | Pigmentary retinal degeneration (HP:0001146) | 2.52363548 |
| 56 | Microretrognathia (HP:0000308) | 2.51075304 |
| 57 | Villous atrophy (HP:0011473) | 2.49888720 |
| 58 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.49888720 |
| 59 | Abnormality of potassium homeostasis (HP:0011042) | 2.49518445 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.48965762 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.46504882 |
| 62 | Abnormality of sodium homeostasis (HP:0010931) | 2.44700744 |
| 63 | Milia (HP:0001056) | 2.44606571 |
| 64 | Myopathic facies (HP:0002058) | 2.43686150 |
| 65 | Gastrointestinal dysmotility (HP:0002579) | 2.42066588 |
| 66 | Abnormality of vitamin B metabolism (HP:0004340) | 2.41475153 |
| 67 | Adrenal overactivity (HP:0002717) | 2.39491888 |
| 68 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.38571198 |
| 69 | Fat malabsorption (HP:0002630) | 2.36071053 |
| 70 | Rhabdomyolysis (HP:0003201) | 2.35491644 |
| 71 | Potter facies (HP:0002009) | 2.35088679 |
| 72 | Facial shape deformation (HP:0011334) | 2.35088679 |
| 73 | Posterior subcapsular cataract (HP:0007787) | 2.33807576 |
| 74 | Abnormal urine phosphate concentration (HP:0012599) | 2.32898715 |
| 75 | Hypotension (HP:0002615) | 2.32067543 |
| 76 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.31647165 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.27755800 |
| 78 | Thin bony cortex (HP:0002753) | 2.27740268 |
| 79 | Abnormal tarsal ossification (HP:0008369) | 2.26926875 |
| 80 | Abnormality of the costochondral junction (HP:0000919) | 2.26233640 |
| 81 | Abnormality of nucleobase metabolism (HP:0010932) | 2.25454255 |
| 82 | Focal segmental glomerulosclerosis (HP:0000097) | 2.24933505 |
| 83 | Megaloblastic anemia (HP:0001889) | 2.20690444 |
| 84 | Muscle fiber inclusion bodies (HP:0100299) | 2.20308289 |
| 85 | Hyperammonemia (HP:0001987) | 2.19694664 |
| 86 | Enlarged epiphyses (HP:0010580) | 2.19458133 |
| 87 | Ureteral stenosis (HP:0000071) | 2.18677844 |
| 88 | Exercise-induced myalgia (HP:0003738) | 2.16580955 |
| 89 | Nephrolithiasis (HP:0000787) | 2.15289023 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 2.15110926 |
| 91 | Eczematoid dermatitis (HP:0000976) | 2.13851922 |
| 92 | Nemaline bodies (HP:0003798) | 2.13391481 |
| 93 | Intrahepatic cholestasis (HP:0001406) | 2.12668191 |
| 94 | Abnormality of glycine metabolism (HP:0010895) | 2.11289390 |
| 95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11289390 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11254146 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11232013 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.11232013 |
| 99 | Metabolic acidosis (HP:0001942) | 2.10510516 |
| 100 | Wide cranial sutures (HP:0010537) | 2.08785372 |
| 101 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.07959919 |
| 102 | Ketoacidosis (HP:0001993) | 2.07199564 |
| 103 | Palpitations (HP:0001962) | 2.01766158 |
| 104 | Late onset (HP:0003584) | 2.01095743 |
| 105 | Cerebral palsy (HP:0100021) | 2.00909121 |
| 106 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00435387 |
| 107 | Ureteral obstruction (HP:0006000) | 2.00297691 |
| 108 | Syncope (HP:0001279) | 2.00195821 |
| 109 | Autoimmune hemolytic anemia (HP:0001890) | 1.99991330 |
| 110 | Glomerulonephritis (HP:0000099) | 1.99867321 |
| 111 | Fragile skin (HP:0001030) | 1.97490425 |
| 112 | Delayed epiphyseal ossification (HP:0002663) | 1.97062091 |
| 113 | Increased connective tissue (HP:0009025) | 1.95697373 |
| 114 | Curly hair (HP:0002212) | 1.93878074 |
| 115 | Ventricular fibrillation (HP:0001663) | 1.93174601 |
| 116 | Generalized aminoaciduria (HP:0002909) | 1.93048216 |
| 117 | Type 1 muscle fiber predominance (HP:0003803) | 1.92826772 |
| 118 | Goiter (HP:0000853) | 1.92544068 |
| 119 | Myoglobinuria (HP:0002913) | 1.92305424 |
| 120 | Pili torti (HP:0003777) | 1.91694089 |
| 121 | Abnormal biliary tract morphology (HP:0012440) | 1.91512293 |
| 122 | Multiple lipomas (HP:0001012) | 1.89390035 |
| 123 | Confusion (HP:0001289) | 1.89201953 |
| 124 | Cupped ribs (HP:0000887) | 1.88947311 |
| 125 | Protuberant abdomen (HP:0001538) | 1.87247337 |
| 126 | Abnormality of the aortic arch (HP:0012303) | 1.87181641 |
| 127 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85814578 |
| 128 | Abnormality of vitamin metabolism (HP:0100508) | 1.82741668 |
| 129 | Nephritis (HP:0000123) | 1.82314738 |
| 130 | Poikilocytosis (HP:0004447) | 1.82128768 |
| 131 | Renal tubular acidosis (HP:0001947) | 1.81455810 |
| 132 | Hypophosphatemia (HP:0002148) | 1.81131757 |
| 133 | Pancreatitis (HP:0001733) | 1.80203754 |
| 134 | Woolly hair (HP:0002224) | 1.79811067 |
| 135 | Abnormal glucose tolerance (HP:0001952) | 1.78860792 |
| 136 | Abnormality of carpal bone ossification (HP:0006257) | 1.78010587 |
| 137 | Epidermoid cyst (HP:0200040) | 1.77122031 |
| 138 | Abnormality of the gastric mucosa (HP:0004295) | 1.75608407 |
| 139 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.75495409 |
| 140 | Abnormal platelet function (HP:0011869) | 1.75110306 |
| 141 | Impaired platelet aggregation (HP:0003540) | 1.75110306 |
| 142 | Rectal prolapse (HP:0002035) | 1.74647007 |
| 143 | Fragile nails (HP:0001808) | 1.73142204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK2 | 6.18494311 |
| 2 | ACVR1B | 6.06396092 |
| 3 | LMTK2 | 5.56134976 |
| 4 | MST4 | 4.73092090 |
| 5 | MST1R | 4.44381337 |
| 6 | FRK | 3.96519278 |
| 7 | OXSR1 | 3.68437872 |
| 8 | WNK4 | 3.58827067 |
| 9 | WNK3 | 3.56881344 |
| 10 | PRKG2 | 3.36509456 |
| 11 | NME1 | 2.85406445 |
| 12 | GRK6 | 2.58902951 |
| 13 | RIPK1 | 2.58676510 |
| 14 | EPHA2 | 2.41040982 |
| 15 | MAP3K10 | 2.36763288 |
| 16 | TLK1 | 2.26731475 |
| 17 | MAP2K2 | 2.09529613 |
| 18 | MAP3K5 | 2.09373338 |
| 19 | PTK6 | 1.95250515 |
| 20 | MAP3K2 | 1.84978703 |
| 21 | STK39 | 1.82020119 |
| 22 | OBSCN | 1.79957410 |
| 23 | PDK2 | 1.56833354 |
| 24 | STK10 | 1.55979366 |
| 25 | ERN1 | 1.53909167 |
| 26 | MAP4K1 | 1.42236111 |
| 27 | EPHA3 | 1.38588459 |
| 28 | TESK1 | 1.36307043 |
| 29 | TRIB3 | 1.34497000 |
| 30 | CDK19 | 1.27998824 |
| 31 | CASK | 1.26493270 |
| 32 | MAP3K12 | 1.25521503 |
| 33 | TAOK3 | 1.24149393 |
| 34 | RIPK4 | 1.22258863 |
| 35 | GRK1 | 1.21352180 |
| 36 | TNIK | 1.19958339 |
| 37 | STK24 | 1.18408443 |
| 38 | MATK | 1.17143916 |
| 39 | AKT3 | 1.15990894 |
| 40 | NUAK1 | 1.15694582 |
| 41 | MYLK | 1.13160561 |
| 42 | EPHB1 | 1.12436036 |
| 43 | EPHA4 | 1.11551837 |
| 44 | EEF2K | 1.10488456 |
| 45 | KSR2 | 1.05543363 |
| 46 | EPHB2 | 1.03232692 |
| 47 | PKN2 | 1.02637675 |
| 48 | SCYL2 | 0.98824179 |
| 49 | MAP3K7 | 0.95448181 |
| 50 | FGFR3 | 0.95100872 |
| 51 | MAPK11 | 0.94595972 |
| 52 | LRRK2 | 0.94537057 |
| 53 | NLK | 0.93953574 |
| 54 | PRKAA2 | 0.90921380 |
| 55 | PAK4 | 0.90106365 |
| 56 | PDGFRA | 0.89819628 |
| 57 | MET | 0.85961849 |
| 58 | PRKCI | 0.84855573 |
| 59 | PIK3CA | 0.84574609 |
| 60 | TTK | 0.83456311 |
| 61 | MAP2K6 | 0.82390201 |
| 62 | MAP3K8 | 0.81784054 |
| 63 | ERBB2 | 0.76450584 |
| 64 | TBK1 | 0.73850838 |
| 65 | MAP3K1 | 0.72152166 |
| 66 | MAP4K2 | 0.71945103 |
| 67 | SIK2 | 0.69094931 |
| 68 | PTK2 | 0.67064209 |
| 69 | CDC42BPA | 0.65879205 |
| 70 | MAP2K1 | 0.65264069 |
| 71 | SGK3 | 0.63974050 |
| 72 | ERBB4 | 0.60406013 |
| 73 | PRKAA1 | 0.59213278 |
| 74 | RET | 0.54524893 |
| 75 | BMPR1B | 0.53287294 |
| 76 | TYK2 | 0.53077607 |
| 77 | PIK3CG | 0.50328472 |
| 78 | FER | 0.48883037 |
| 79 | MAPKAPK3 | 0.48261900 |
| 80 | CDK8 | 0.48007212 |
| 81 | PDK1 | 0.47345534 |
| 82 | PBK | 0.47002284 |
| 83 | CAMK2D | 0.46949719 |
| 84 | TAOK1 | 0.45400177 |
| 85 | IRAK3 | 0.45331549 |
| 86 | PHKG2 | 0.45315699 |
| 87 | PHKG1 | 0.45315699 |
| 88 | MELK | 0.41434196 |
| 89 | RAF1 | 0.40853315 |
| 90 | DMPK | 0.40832165 |
| 91 | MAPK7 | 0.40546129 |
| 92 | PDPK1 | 0.40170289 |
| 93 | MAP3K3 | 0.39336284 |
| 94 | BCR | 0.38014084 |
| 95 | PRKCZ | 0.37872774 |
| 96 | JAK1 | 0.37241728 |
| 97 | PRPF4B | 0.35054284 |
| 98 | CAMK2G | 0.34404373 |
| 99 | MUSK | 0.32274915 |
| 100 | BLK | 0.32216892 |
| 101 | PDK4 | 0.31854839 |
| 102 | PDK3 | 0.31854839 |
| 103 | PRKCA | 0.29651482 |
| 104 | LIMK1 | 0.28461596 |
| 105 | TTN | 0.27656738 |
| 106 | FGFR4 | 0.27561579 |
| 107 | MAP3K11 | 0.26841333 |
| 108 | SRC | 0.26503649 |
| 109 | IRAK1 | 0.25136055 |
| 110 | GSK3A | 0.24790529 |
| 111 | AURKB | 0.24049222 |
| 112 | CSK | 0.24012328 |
| 113 | MAP3K13 | 0.23876131 |
| 114 | PRKACG | 0.23504436 |
| 115 | CDK6 | 0.23301062 |
| 116 | BMX | 0.22293798 |
| 117 | PIM2 | 0.22039810 |
| 118 | ICK | 0.21959120 |
| 119 | BCKDK | 0.21273903 |
| 120 | PAK2 | 0.21264456 |
| 121 | CAMK2B | 0.20418682 |
| 122 | JAK2 | 0.20253943 |
| 123 | DYRK1B | 0.20157709 |
| 124 | DDR2 | 0.19409474 |
| 125 | PDGFRB | 0.18182555 |
| 126 | AKT2 | 0.17523361 |
| 127 | TESK2 | 0.17273910 |
| 128 | FYN | 0.17212849 |
| 129 | ABL2 | 0.16743079 |
| 130 | CAMK2A | 0.15861818 |
| 131 | PAK1 | 0.15857172 |
| 132 | STK11 | 0.15752183 |
| 133 | PAK3 | 0.15550144 |
| 134 | PRKG1 | 0.15458145 |
| 135 | PRKCD | 0.15416628 |
| 136 | CSNK1A1 | 0.15296498 |
| 137 | NEK1 | 0.15294400 |
| 138 | PRKCQ | 0.14801825 |
| 139 | ROCK1 | 0.14572337 |
| 140 | STK38L | 0.14483811 |
| 141 | SGK223 | 0.14437211 |
| 142 | SGK494 | 0.14437211 |
| 143 | CDK7 | 0.14429786 |
| 144 | CDK4 | 0.14135023 |
| 145 | HIPK2 | 0.13579673 |
| 146 | SIK3 | 0.12205609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.71777799 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 3.62067077 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.42998347 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.10181152 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.05972107 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.90980027 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.89522737 |
| 8 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.69459396 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52498323 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.36555820 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.26291536 |
| 12 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.23648343 |
| 13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.17203942 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.16950983 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.07614558 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01839834 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.95291987 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.87224791 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85149748 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82569951 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.81368935 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81163507 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76060719 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73819470 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67617417 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.66493392 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45876862 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45837398 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.45203942 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42596621 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38921174 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37249864 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36212485 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33319637 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32187145 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30675661 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30498698 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28860968 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28489506 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.23556311 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20016534 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17326283 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16674817 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13390563 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12892233 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12872868 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.06971870 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.03140951 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02456050 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97656633 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93939476 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.93313265 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92092566 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90049107 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89969502 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88996135 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82640907 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80755243 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73283662 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66194569 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65542517 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.64850343 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.62302440 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.61605159 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.61256443 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60889554 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59317772 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58182230 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54299048 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52652901 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51510782 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.50966424 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48992796 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46977379 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.46930296 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.46924892 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45205875 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44592578 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44079107 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43150496 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.42431268 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42277423 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41122532 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39153741 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38212992 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37407663 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37100432 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36659597 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.34819776 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34703047 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.33337631 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30759011 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29557131 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26595592 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.25788533 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.25246555 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24384753 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23439920 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21327367 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.19792813 |
| 101 | Insulin secretion_Homo sapiens_hsa04911 | 0.18951576 |
| 102 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.18045862 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18021810 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.17696155 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.17544490 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.16969679 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16763392 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16757330 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16683772 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16409987 |
| 111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.15852821 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15493394 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14186654 |
| 114 | Leishmaniasis_Homo sapiens_hsa05140 | 0.14118575 |
| 115 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.13545545 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.12946153 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11352768 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.10527154 |
| 119 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10426630 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.09771216 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09069259 |
| 122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.09025558 |
| 123 | Influenza A_Homo sapiens_hsa05164 | 0.06878291 |
| 124 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06698977 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.05077225 |
| 126 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04024781 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.03204868 |
| 128 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.03152049 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.02973084 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.02903845 |

